Amarnath P. Rajendran

Edmonton, AB T6G2V2, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Exploring interneuron conduction time in the motor cortex and the link to motor function in individuals with chronic stroke.

Exploring interneuron conduction time in the motor cortex and the link to motor function in individuals with chronic stroke.

Journal: Journal of neurophysiology
Published: September 02, 2026

Technology for Nucleic Acid Delivery in the Treatment of Hematological Malignancies.

Technology for Nucleic Acid Delivery in the Treatment of Hematological Malignancies.

Journal: Advanced drug delivery reviews
Published: August 24, 2025

Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic Delivery.

Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic Delivery.

Journal: Advanced healthcare materials
Published: April 23, 2025

In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington's Disease.

In Vitro Efficacy of PEI-Derived Lipopolymers in Silencing of Toxic Proteins in a Neuronal Model of Huntington's Disease.

Journal: Pharmaceutics
Published: April 04, 2025

Lipid-Modified PEI Derivative-Based Binary/Ternary Polyplex Formulations for the Delivery of pDNA and mRNA in Primary Cells.

Lipid-Modified PEI Derivative-Based Binary/Ternary Polyplex Formulations for the Delivery of pDNA and mRNA in Primary Cells.

Journal: Biomacromolecules
Published: March 28, 2025

Lipopolymers as the Basis of Non-Viral Delivery of Therapeutic siRNA Nanoparticles in a Leukemia (MOLM-13) Model.

Lipopolymers as the Basis of Non-Viral Delivery of Therapeutic siRNA Nanoparticles in a Leukemia (MOLM-13) Model.

Journal: Biomolecules
Published: October 22, 2024

Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia.

Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia.

Journal: ACS pharmacology & translational science
Published: June 03, 2024

Tuning the Potency of Farnesol-Modified Polyethylenimine with Polyanionic Trans-Booster to Enhance DNA Delivery.

Tuning the Potency of Farnesol-Modified Polyethylenimine with Polyanionic Trans-Booster to Enhance DNA Delivery.

Journal: ACS biomaterials science & engineering
Published: February 09, 2024

Biodistribution of Therapeutic Small Interfering RNAs Delivered with Lipid-Substituted Polyethylenimine-Based Delivery Systems.

Biodistribution of Therapeutic Small Interfering RNAs Delivered with Lipid-Substituted Polyethylenimine-Based Delivery Systems.

Journal: Molecular pharmaceutics
Published: January 31, 2024

Designing Nanomedicines for Breast Cancer Therapy.

Designing Nanomedicines for Breast Cancer Therapy.

Journal: Biomolecules
Published: September 15, 2023

Transfection Efficacy and Cellular Uptake of Lipid-Modified Polyethyleneimine Derivatives for Anionic Nanoparticles as Gene Delivery Vectors.

Transfection Efficacy and Cellular Uptake of Lipid-Modified Polyethyleneimine Derivatives for Anionic Nanoparticles as Gene Delivery Vectors.

Journal: ACS applied bio materials
Published: February 28, 2023

Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery.

Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery.

Journal: Frontiers in bioengineering and biotechnology
Published: November 30, 2022
Showing 1-12 of 12

Last Updated: 09/26/2026